Skip to main content
PCVX
NASDAQ Life Sciences

Vaxcyte Doses First Participant in Phase 1 Study for VAX-A1 Strep Vaccine, Targeting Major Unmet Need

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$47.41
Mkt Cap
$6.846B
52W Low
$29.08
52W High
$65
52W Position info
63% above low
Off High info
27% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

PCVX sits 63% above its 52-week low of $29.08.

Summary

Vaxcyte has dosed the first participant in its Phase 1 study for VAX-A1, an investigational vaccine candidate targeting Group A Streptococcus. This marks the entry of a new program into clinical trials, diversifying Vaxcyte's pipeline beyond its lead VAX-31 pneumococcal vaccine, which recently completed Phase 3 enrollment. Group A Strep is responsible for a significant global disease burden with no approved vaccine, indicating a large potential market for a successful preventative solution. Topline data from this Phase 1 study is anticipated in the second half of 2027.

At the time of this announcement, PCVX was trading at $47.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.8B. The 52-week trading range was $29.08 to $65.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

PCVX - Latest Insights

PCVX
Nov 04, 2026, 5:07 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $65.68
Real-time Price: $58.08 info
Change: -$7.61 (-12%) info
Market Cap: $9.206B info
PCVX
Nov 04, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $65.68
Real-time Price: $58.08 info
Change: -$7.61 (-12%) info
Market Cap: $9.206B info
PCVX
Oct 09, 2026, 4:42 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $71.12
Real-time Price: $58.08 info
Change: -$13.05 (-18%) info
Market Cap: $9.206B info
PCVX
Oct 08, 2026, 4:30 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $64.94
Real-time Price: $58.08 info
Change: -$6.86 (-11%) info
Market Cap: $9.206B info
PCVX
Oct 07, 2026, 6:05 AM EDT
Filing Type: FWP
Importance Score:
8
Price at Filing: $66.40
Real-time Price: $58.08 info
Change: -$8.33 (-13%) info
Market Cap: $9.206B info